Results 1 to 10 of about 206,338 (340)

Pediatric Ventricular Assist Device [PDF]

Korean Circulation Journal, 2019
There have been great advances in ventricular assist device (VAD) treatment for pediatric patients with advanced heart failure. VAD support provides more time for the patient in the heart transplant waiting list. Augmented cardiac output improves heart failure symptoms, end-organ function, and general condition, and consequently provides beneficial ...
Yu Rim Shin, Young-Hwan Park, Han Ki Park   +2 more
openaire   +5 more sources

Stroke in pediatric ventricular assist device support [PDF]

JHLT Open
Stroke continues to be one of the most significant hemocompatibility related adverse event in pediatric ventricular assist device support. Tremendous gains have been made in reducing the incidence of stroke across all ages, diagnoses and device types ...
Christina VanderPluym, MD, Ryan Kobayashi, MD, Michael Rivkin, MD   +2 more
doaj   +2 more sources

Recent Developments in Ventricular Assist Device Therapy [PDF]

Reviews in Cardiovascular Medicine
The evolution of left ventricular assist devices (LVADs) from large, pulsatile systems to compact, continuous-flow pumps has significantly improved implantation outcomes and patient mobility. Minimally invasive surgical techniques have emerged that offer
Angel Moctezuma-Ramirez, Haseeb Mohammed, Austin Hughes, Abdelmotagaly Elgalad   +3 more
doaj   +2 more sources

Echocardiography in left ventricular assist device

Heart Views, 2010
LVAD = Left Ventricular Assist Device; LV = Left Ventricle; LA = Left Atrium; AO = Aorta.
Sherif M Helmy, Alia Albinali, Rachel Hajar   +2 more
doaj   +4 more sources

Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center [PDF]

The Korean Journal of Internal Medicine, 2022
Background/Aims The continuous flow left ventricular assist device (cf-LVAD) has improved the survival of chronic end-stage heart failure (HF) patients.
Yoonjee Park, Darae Kim, Jeong Hoon Yang, Yang Hyun Cho, Jin-Oh Choi, Eun-Seok Jeon   +5 more
doaj   +1 more source

Racial and Sex Inequities in the Use of and Outcomes After Left Ventricular Assist Device Implantation Among Medicare Beneficiaries

JAMA Network Open, 2022
This cohort study assesses inequities in access and outcomes in the receipt of left ventricular assist device (LVAD) therapy for Black and female patients in the US.
T. Cascino, S. Somanchi, Monica M Colvin, Grace S Chung, A. Brescia, M. Pienta, M. Thompson, James W. Stewart, Devraj Sukul, Daphne C. Watkins, F. Pagani, D. Likosky, K. Aaronson, J. McCullough   +13 more
semanticscholar   +1 more source

Percutaneous left ventricular assist devices in refractory cardiac arrest: The role of chest compressions

Resuscitation Plus, 2023
Background: Recent studies describe an emerging role for percutaneous left ventricular assist devices such as Impella CP® as rescue therapy for refractory cardiac arrest.
Adam L. Gottula, Brendan M. McCracken, Takahiro Nakashima, Nicholas L. Greer, Traci A. Cramer, Nadia R. Sutton, Kevin R. Ward, Robert W. Neumar, Mohamad Hakam Tiba, Cindy H. Hsu   +9 more
doaj   +1 more source

Ventricular assist devices [PDF]

Continuing Education in Anaesthesia Critical Care & Pain, 2012
Heart failure occurs in 1% of the UK adult population yet represents 5% of all hospital admissions, according to the 2008/09 National Heart Failure audit (http://www.ic.nhs.uk/ webfiles/publications/002_Audits/NHS_IC_ HEART_FAILURE_AUDIT_13-12-10.pdf ).
Paul Harris, Lakshminarasimhan Kuppurao
openaire   +3 more sources

Right and left ventricular assist devices are an option for bridge to heart transplantCentral MessagePerspective

JTCVS Open, 2022
Background: Patients with a left ventricular assist device with right ventricular failure are prioritized on the heart transplant waitlist; however, their post-transplant survival is less well characterized.
Yaron D. Barac, MD, PhD, Ronen Toledano, MD, Oliver K. Jawitz, MD, Jacob N. Schroder, MD, Mani A. Daneshmand, MD, Chetan B. Patel, MD, Dan Aravot, MD, Carmelo A. Milano, MD   +7 more
doaj   +1 more source

Primary results of long‐term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants

European Journal of Heart Failure, 2021
The MOMENTUM 3 pivotal trial established superiority of the HeartMate 3 (HM3) left ventricular assist device (LVAD), a fully magnetically levitated centrifugal‐flow pump, over the HeartMate II axial‐flow pump.
M. Mehra, J. Cleveland, N. Uriel, J. Cowger, S. Hall, D. Horstmanshof, Y. Naka, C. Salerno, J. Chuang, Christopher Williams, D. Goldstein   +10 more
semanticscholar   +1 more source